Albert Invent
Albert Invent provides a cloud-based, AI-powered R&D platform for the chemistry and materials science industry, accelerating product development.
Secondary Market Price
Secondary Market Price
How Albert Invent Measures Up
To help you manage your Albert Invent equity, Prospect has run the company through our machine learning model.
Prospect Rating
TBD
We are currently gathering the data needed to complete our evaluation of Albert Invent. Check back soon for our rating and four-year forecast of the company's worth.
Exit Risk
TBD
We are still gathering data on Albert Invent to train our machine learning model. Check back soon for our exit risk rating for Albert Invent!
Funding Stage
Series B
For you as a potential employee, a Series B company like Albert Invent offers a great balance. You're joining a company that has found its footing and is focused on scaling, which means more stability than an early-stage startup but still plenty of room for growth.
Secondary Market Price Chart
Create a free account to unlock real-time secondary market prices and future projections of Albert Invent's value.
Sign up to Unlock the Latest DataData will be available soon.
Sign up to receive notifications when it is available.
Prospect Projected Future Albert Invent Prices
Prospect’s machine learning model has been trained on the same data top-tier investors use to project the likely range of outcomes for Albert Invent's equity. Create a free account to view 10th-90th percentile projections over 2, 4, and 6 years.
Powerful tools to earn more from your equity
Company Description
Albert Invent develops a cloud-based platform that utilizes applied AI to accelerate research and development within the chemical and materials science industries. The platform is designed to unify experimental data, streamline R&D and regulatory processes, and provide AI-driven insights for formulation and product development. Founded in 2022 by Nick Talken, Ken Kisner, Neelesh Vaikhary, and Zack Kisner, the company is headquartered in Oakland, California, with additional offices in India. Its platform is used by scientists in more than 30 countries.
The company has recently focused on expanding its industry partnerships and platform capabilities. In February 2025, Albert Invent secured $20 million in a Series A1 funding round with investors including JPMorgan Chase & Co. It has engaged in collaborations with companies such as Nouryon, with whom it developed an AI-powered formulation discovery studio, and has published case studies on digital transformation projects with clients like Marabu Inks. Company executives frequently present at industry events, including the Western Coatings Symposium and Future Labs Live USA, discussing topics such as the application of AI in R&D and strategies for digital transformation.
- Index Ventures
- Coatue
- F-Prime
- TCV
- Homebrew
- Co-Founder, CEO Nick Talken
- Co-Founder, CFO Ken Kisner
- Co-Founder, CTO Neelesh Vaikhary
- Co-Founder, Head of Product Zack Kisner
Peer Group Comparison
Vs Peer Group of >$4B Startups
Frequently Asked Questions
Joining Anduril as an employee is another way to acquire equity, typically through stock options included in compensation packages.
Is Albert Invent worth joining?
Deciding if a startup like Albert Invent is worth joining depends on your personal risk tolerance and career goals, as early-stage companies offer high growth potential but also significant risk. Platforms like Prospect can help you evaluate the opportunity by providing data-driven insights on private companies, similar to those used by venture capitalists.
What should I do with my Albert Invent stock?
Managing your private company stock involves making strategic decisions about when to exercise options, hold, or sell to maximize your post-tax value. You can use specialized tools from platforms like Prospect to create a personalized strategy based on tax implications, market conditions, and your financial goals.
Can you sell Albert Invent stock?
As a private company, selling Albert Invent stock is more restricted than selling shares of a public company and typically occurs during specific events like tender offers or on secondary markets. Resources like Prospect offer tools and data on secondary market pricing to help you navigate these opportunities and decide on the optimal time to sell.
How can I find the value of my Albert Invent stock?
The value of stock in a private company like Albert Invent is typically determined by its latest 409A valuation, which is based on factors like recent funding rounds and company performance. To get an independent projection of your equity's potential future worth, you can use platforms like Prospect, which leverage VC-grade data and predictive models.
What is Albert Invent's equity worth?
Pinpointing the exact worth of equity in a private company like Albert Invent is challenging, as its value fluctuates based on performance, market conditions, and future fundraising. You can use an equity calculator and analysis tools from platforms like Prospect to model different scenarios and project the potential value of your holdings.
What is Albert Invent's stock ticker symbol?
Albert Invent does not have a stock ticker symbol because it is a private company and its shares are not traded on public stock exchanges. Ticker symbols are only assigned to companies once they complete an Initial Public Offering (IPO) and are listed on an exchange like the NYSE or NASDAQ.
Can I buy or sell Albert Invent stock?
Buying or selling stock in a private company like Albert Invent is possible but is generally restricted to employees, accredited investors, or transactions on secondary markets. Platforms like Prospect provide data-driven analysis on private companies, which can help inform decisions for both current shareholders and potential investors.
What is the criteria to buy or invest in Albert Invent stock?
The criteria for investing in a private company like Albert Invent typically require you to be an accredited investor or an employee exercising stock options. Before investing, it's crucial to perform due diligence using resources like Prospect to evaluate the company's fundamentals, growth potential, and valuation.
